CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy

Blood Adv. 2020 Oct 13;4(19):4665-4668. doi: 10.1182/bloodadvances.2020002502.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Child
  • Humans
  • Immunotherapy
  • Neoplasm Recurrence, Local
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*